A South Philly artist and motorcycle enthusiast turned to sculpture to help him and his family process his ALS diagnosis. An installation is at the Parkway Central Library until Friday.

Amini: The majority of these patients — except at this time stage 1 — will need systemic therapy as part of their therapy, whether it is in the locally advanced resectable or unresectable case or ...

Amini: From a radiation standpoint, this has changed the landscape of our field. A large proportion of my practice is stage IV disease, where patients who are on these excellent systemic therapies are ...

We read with interest the results of the HARMONi-6 trial by Zhiwei Chen and colleagues,1 which showed that ivonescimab plus chemotherapy improved progression-free survival versus tislelizumab plus ...

Reported updated results from 12 patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led study ...

Early PrimeC treatment slowed functional decline and reduced the risk of death or ALS complications for ALS patients in a ...

Results supported by key neuroaxonal injury biomarkers pNfH and NfL after six months of treatmentAP-101 is an investigational human-derived antibody therapeutic that selectively targets the misfolded, ...

As Congress debates renewing the Act for ALS, it must prepare for the coming era of precision ALS medicine by prioritizing ...

ASX healthcare companies are teaming up with universities as industry and educational institutions working together to develop new therapies.

Acurastem received a grant to develop ALS therapies targeting SYF2, a regulator of TDP-43, in collaboration with academic research teams.

Reported positive Phase 2b RewinD-LB clinical data at CTAD 2025; additional analyses to be presented at AD/PD 2026Obtained alignment with FDA and ...

Veteran journalist Oren Nahari revealed he has ALS, a severe degenerative neurological disease. How many Israelis are diagnosed each year and what are the chances of a cure in the coming years?